市場調查報告書
商品編碼
1464944
CBD 成分市場:按來源、類型和應用分類 - 2024-2030 年全球預測CBD Ingredients Market by Source (Hemp-Derived CBD, Marijuana-Derived CBD), Type (Broad Spectrums, Full Spectrums, Isolate Spectrums), Application - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
CBD原料市場規模預計2023年為65.2億美元,2024年達到73.8億美元,預計2030年將達到163.8億美元,複合年成長率為14.05%。
大麻二酚 (CBD) 成分市場包括植物來源的所有產品和成分,特別關注 CBD,這是一種以其潛在健康益處而聞名的非精神活性化合物。由於其應用範圍廣泛,該市場延伸至藥品、化妝品、食品和飲料、寵物護理等各個領域。這涉及從種植和提取到將 CBD 注入的產品分銷給最終消費者,凸顯了複雜的價值鏈。 CBD成分應用於藥品、營養補充、化妝品、食品食品和飲料等各領域。在藥物領域,CBD 用於治療焦慮、癲癇和慢性疼痛等疾病。在營養補充領域,將其納入促進健康的補充品中。含有 CBD 的化妝品以其發炎和抗氧化特性而聞名,食品和飲料行業正在使用 CBD 來創造以健康為導向的食用產品。有幾個因素正在推動 CBD 成分市場的成長,包括全球慢性病的流行、CBD 成分研發投資的增加以及消費者對健康和自然療法的興趣日益濃厚。然而,大麻二酚市場面臨著一定的挑戰,包括 CBD 產品嚴格的品質和安全標準、消費者的誤解以及圍繞大麻產品的恥辱。同時,新的 CBD 配方和輸送方法的持續開發,以及與食品、食品和飲料、化妝品和製藥公司的策略合作夥伴關係,為 CBD 成分市場提供了潛在的成長機會。
主要市場統計 | |
---|---|
基準年[2023] | 65.2億美元 |
預測年份 [2024] | 73.8億美元 |
預測年份 [2030] | 163.8億美元 |
複合年成長率(%) | 14.05% |
類型治療效果增加了對全光譜CBD 的偏好
頻譜CBD 具有天然大麻素的綜合特徵,不包括 THC(四氫大麻酚)。由於大麻素和萜烯的綜合作用,這種類型的 CBD 提供了一種娛樂效果,被認為可以增加產品的整體效力,而不會產生與 THC 相關的精神作用。全光譜CBD 含有大麻植物中發現的所有大麻素,包括 THC。這種成分保持了植物化學成分的完整性,並提供了 CBD 消費的整體方法。 THC 的存在,即使是微量,與其他大麻素和萜烯一起,也可以有助於娛樂效果並增強產品的治療效果。 隔離群 頻譜 CBD,通常稱為 CBD隔離群,幾乎是 100% 純 CBD。在萃取過程中,所有其他大麻素、萜烯和類黃酮都被移除,產生僅含有大麻二酚的產品。這種類型的 CBD 成分不含 THC 或大麻植物中發現的其他化合物,使其成為尋求 CBD 純粹功效而不受其他大麻素或萜烯影響的消費者的好選擇。它常見於依賴 CBD 純度和濃度的製藥應用、某些營養補充食品針對特定健康目標的產品。
將 CBD 成分的應用擴展到支持整體健康的營養補充
在食品和飲料領域,CBD 主要用於其潛在的健康益處,而不具有與 THC 相關的精神作用。含有 CBD 的飲料、巧克力和烘焙點心等產品迎合了尋求放鬆、減少焦慮和改善睡眠品質的消費者。該行業受益於天然和健康產品的持續趨勢。 CBD 因其發炎、鎮痛和神經保護特性而受到食品營養補充的歡迎。該細分市場的消費者專注於健康和保健,並利用 CBD 的潛力來提振情緒、幫助運動後恢復和支持整體健康。在個人護理和化妝品行業,CBD 的發炎和抗氧化特性被用於護膚產品,如乳霜、精華液和香膏。這些產品的目標使用者是尋找促進皮膚健康、緩解痤瘡等狀況並提供抗老化功效的天然成分的使用者。在製藥領域,CBD 的用途多種多樣,主要集中在其治療特定醫療狀況的潛力。目前正在研究 CBD 對癲癇、焦慮症、多發性硬化症和癌症等慢性疾病症狀管理的有效性。總之,市場區隔是多種多樣的,每個應用領域都針對特定的消費者需求和偏好。食品和飲料、食品營養補充於一般健康促進和健康最佳化,而個人護理、化妝品和藥品則著重於解決特定健康狀況或促進皮膚健康的產品。
區域洞察
由於合法化、社會接受度的提高以及 CBD 產品的擴張,以美國和加拿大為中心的北美地區仍然是 CBD 成分的主要市場。特別是在美國,2018 年農業法案後的監管發展正在支持 CBD 在消費和製藥領域的擴張。南美洲注意到人們對 CBD 成分的興趣激增,特別是烏拉圭和哥倫比亞正在採取積極措施實現大麻合法化。該地區在農業能力和監管轉變的支持下顯示出成長潛力。歐洲 CBD 市場呈現出監管多樣性,在有利的法規環境和高消費者興趣的推動下,德國、英國和瑞士等國家處於領先地位。然而,歐盟的新型食品法規標誌著一個重要的監管里程碑,為 CBD食品和補充品鋪平了道路。中東對於 CBD 產品來說是一個充滿挑戰的市場,許多國家都有嚴格的大麻管制法。然而,人們對 CBD 的藥用興趣不大,但日益成長。非洲 CBD 市場正處於早期開拓階段,其中南非是最引人注目的市場。由於人們對 CBD 的健康和保健益處的認知不斷增強,非洲大陸在種植大麻和開拓CBD 市場方面都表現出了希望。亞太地區對 CBD 的興趣正在緩慢但穩定地成長,這主要是由澳大利亞和泰國等國家推動的。儘管對 CBD 消費有嚴格的監管,但中國已成為 CBD 大麻種植和出口市場的重要參與者。中國最近的專利集中在大麻遺傳學和 CBD 萃取技術上。日本對THC保持嚴格的零容忍政策,並強調CBD的純度。最近的放鬆管制導致注入 CBD 的產品數量增加,從護膚到補充品。印度的 CBD 市場正處於起步階段,普及還有重大的法律和文化障礙。然而,阿育吠陀中大麻的傳統用途和日益成長的意識表明了未來的市場潛力。
FPNV定位矩陣
FPNV定位矩陣對於評估CBD成分市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可對 CBD 成分市場供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4. 競爭評估和情報:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。
5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1.CBD原料市場的市場規模與預測是多少?
2. CBD 成分市場預測期內需要考慮投資的產品、細分市場、應用和領域有哪些?
3.CBD原料市場的技術趨勢與法規結構是什麼?
4.CBD原料市場主要供應商的市場佔有率是多少?
5.進入CBD原料市場的合適型態和策略手段是什麼?
[180 Pages Report] The CBD Ingredients Market size was estimated at USD 6.52 billion in 2023 and expected to reach USD 7.38 billion in 2024, at a CAGR 14.05% to reach USD 16.38 billion by 2030.
The cannabidiol (CBD) ingredients market includes all products and raw materials derived from the hemp plant, specifically focusing on CBD, a non-psychoactive compound known for its potential health benefits. The market spans various sectors, including pharmaceuticals, cosmetics, food and beverages, and pet care, owing to its broad application range. The scope extends from cultivation and extraction to distributing CBD-infused products to end consumers, highlighting an intricate value chain. CBD ingredients find applications across various sectors, including pharmaceuticals, nutraceuticals, cosmetics, and food and beverages. In pharmaceuticals, CBD is used for its therapeutic properties in treating conditions such as anxiety, epilepsy, and chronic pain. In the nutraceutical sector, it is incorporated into supplements for wellness benefits. Cosmetics infused with CBD are known for their anti-inflammatory and antioxidant properties, while the food and beverage industry utilizes CBD to create wellness-oriented edible products. Several factors propel the growth of the CBD ingredients market, including the growing prevalence of chronic diseases globally, increased investment in R&D of CBD ingredients, and increasing consumer focus on wellness and natural remedies. However, the cannabidiol market is facing certain challenges, such as stringent quality and safety standards required for CBD products, consumer misconceptions, and the stigma associated with cannabis products. On the other hand, the ongoing development of novel CBD formulations and delivery methods and strategic partnerships with food, beverage, cosmetics, and pharmaceutical companies present potential growth opportunities for the CBD ingredients market.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 6.52 billion |
Estimated Year [2024] | USD 7.38 billion |
Forecast Year [2030] | USD 16.38 billion |
CAGR (%) | 14.05% |
Type: Increasing preference for full spectrum CBD due to its therapeutic benefits
Broad Spectrum CBD is characterized by its comprehensive profile of naturally occurring cannabinoids, excluding THC (tetrahydrocannabinol). This type of CBD offers the entourage effect, whereby the combined effect of cannabinoids and terpenes is believed to enhance the product's overall efficacy without the psychoactive effects associated with THC. Full Spectrum CBD includes all cannabinoids found in the cannabis plant, including THC. This composition maintains the integrity of the plant's chemical profile, offering a holistic approach to CBD consumption. The presence of THC, even in minimal amounts, along with additional cannabinoids and terpenes, contributes to the entourage effect, potentially increasing the therapeutic benefits of the product. Isolate Spectrum CBD, often referred to as CBD Isolate, is nearly 100% pure CBD. During the extraction process, all other cannabinoids, terpenes, and flavonoids are removed, resulting in a product that contains solely cannabidiol. This type of CBD ingredient is free from THC and any other compounds found in the cannabis plant, making it a suitable option for consumers looking for the pure effects of CBD without the influence of other cannabinoids or the terpene profile. It's commonly found in pharmaceutical applications, certain dietary supplements, and products targeting specific wellness goals that rely on the purity and concentration of CBD.
Application: Expanding application of CBD ingredients in nutraceuticals & dietary supplements to support overall health
In the food & beverage sector, CBD is predominantly utilized for its potential health benefits without the psychoactive effects associated with THC. Products such as CBD-infused beverages, chocolates, and baked goods cater to consumers seeking relaxation, reduced anxiety, and improved sleep quality. This sector benefits from the ongoing trend towards natural and wellness-focused products. The nutraceuticals & dietary supplements segment embraces CBD for its anti-inflammatory, analgesic, and neuroprotective properties. Consumers in this segment focus on health and wellness, leveraging CBD's potential to enhance mood, aid in recovery post-exercise, and support overall health. In the personal care & cosmetics industry, CBD's anti-inflammatory and antioxidant properties are harnessed in products aimed at skin care, such as creams, serums, and balms. These items target users looking for natural ingredients to enhance skin health, alleviate conditions including acne, and provide anti-aging benefits. The pharmaceutical sector presents a significantly different application for CBD, focusing on its therapeutic potential for treating specific medical conditions. There is ongoing research into CBD's effectiveness for epilepsy, anxiety disorders, and symptom management for chronic diseases such as multiple sclerosis and cancer. In conclusion, the CBD ingredients market is diverse, with each application segment catering to specific consumer needs and preferences. While food & beverage and nutraceuticals & dietary supplements focus on general wellness and health optimization, personal care & cosmetics and Pharmaceutical segments leverage CBD's therapeutic potential to address specific health conditions and enhance skin health.
Regional Insights
The North American region, notably the United States and Canada, continues to be a major market for CBD ingredients due to increasing legalization, societal acceptance, and an expanding array of CBD-infused products. Regulatory advancements, especially in the U.S. following the 2018 Farm Bill, have supported the expansion of CBD in both consumer and pharmaceutical domains. In South America, the burgeoning interest in CBD ingredients is noteworthy, particularly in Uruguay and Colombia, which have taken progressive steps toward cannabis legalization. This region shows growth potential bolstered by agricultural capabilities and regulatory shifts. Europe's CBD market exhibits considerable diversity in regulation and countries such as Germany, the UK, and Switzerland are at the forefront, driven by favorable regulatory atmospheres and high consumer interest. However, the EU's Novel Food Regulation has been a critical regulatory milestone, providing a pathway for CBD foods and supplements. The Middle East presents a challenging market for CBD products, with stringent anti-cannabis laws across many countries. However, there is a small but growing interest in CBD for medicinal purposes. Africa's CBD market is in early development, with South Africa being the most notable market. The continent shows potential for both the cultivation of hemp and the development of CBD markets, driven by a growing awareness of CBD's health and wellness benefits. The APAC region is witnessing a slow but steady interest in CBD, primarily led by countries such as Australia and Thailand. China is appearing as a significant player in the CBD hemp cultivation and export markets despite stringent regulations around CBD consumption. Recent patents in China focus on hemp genetics and CBD extraction technologies. Japan maintains a strict zero-tolerance policy for THC, placing an emphasis on CBD purity. Recent regulatory relaxations have led to an increase in available CBD-infused products, from skincare to supplements. India's CBD market is in its nascent stages, with significant legal and cultural barriers to widespread adoption. However, the traditional use of cannabis in Ayurvedic practices and growing awareness signal a future market potential.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the CBD Ingredients Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the CBD Ingredients Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the CBD Ingredients Market, highlighting leading vendors and their innovative profiles. These include Aurora Cannabis Inc., Bedrocan, BIOTA Biosciences LLC, CannazALL, Cannoid LLC, Canopy Growth Corp., CBD American Shaman LLC, CV Sciences, Inc., Elixinol, Endoca BV, Folium Biosciences, Gaia Botanics, Global Cannabinoids, Green Roads Inc., Happie Hemp Pvt. Ltd., Isodiol International Inc,, Kazmira LLC, Maricann, Inc., Medical Marijuana Inc., Mile High Labs International Inc., NuLeaf Naturals, LLC, PharmaHemp d.o.o., Rhizo Sciences, Sequoya, and SPARKCBD.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the CBD Ingredients Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the CBD Ingredients Market?
3. What are the technology trends and regulatory frameworks in the CBD Ingredients Market?
4. What is the market share of the leading vendors in the CBD Ingredients Market?
5. Which modes and strategic moves are suitable for entering the CBD Ingredients Market?